MX340993B - Agentes de suministro de acido fenilalquilcarboxilico. - Google Patents

Agentes de suministro de acido fenilalquilcarboxilico.

Info

Publication number
MX340993B
MX340993B MX2009008542A MX2009008542A MX340993B MX 340993 B MX340993 B MX 340993B MX 2009008542 A MX2009008542 A MX 2009008542A MX 2009008542 A MX2009008542 A MX 2009008542A MX 340993 B MX340993 B MX 340993B
Authority
MX
Mexico
Prior art keywords
acid delivery
delivery agents
phenylalkylcarboxylic acid
phenylalkylcarboxylic
compounds
Prior art date
Application number
MX2009008542A
Other languages
English (en)
Other versions
MX2009008542A (es
Inventor
Stephen V Pusztay
David Gschneidner
Original Assignee
Emisphere Tech Inc *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Tech Inc * filed Critical Emisphere Tech Inc *
Publication of MX2009008542A publication Critical patent/MX2009008542A/es
Publication of MX340993B publication Critical patent/MX340993B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención provee compuestos de ácido fenilalquilcarboxílico y composiciones que contienen dichos compuestos, para facilitar el suministro de agentes biológicamente activos.
MX2009008542A 2007-02-08 2008-02-08 Agentes de suministro de acido fenilalquilcarboxilico. MX340993B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88892707P 2007-02-08 2007-02-08
PCT/US2008/053429 WO2008112368A2 (en) 2007-02-08 2008-02-08 Phenylalkylcarboxylic acid delivery agents

Publications (2)

Publication Number Publication Date
MX2009008542A MX2009008542A (es) 2009-11-10
MX340993B true MX340993B (es) 2016-08-02

Family

ID=39760306

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008542A MX340993B (es) 2007-02-08 2008-02-08 Agentes de suministro de acido fenilalquilcarboxilico.

Country Status (9)

Country Link
US (4) US20110046050A1 (es)
EP (1) EP2114145B1 (es)
JP (1) JP5544169B2 (es)
CN (2) CN101616583A (es)
BR (1) BRPI0807285A2 (es)
CA (1) CA2676930C (es)
ES (1) ES2657484T3 (es)
MX (1) MX340993B (es)
WO (1) WO2008112368A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2114145B1 (en) * 2007-02-08 2017-11-01 Emisphere Technologies, Inc. Phenylalkylcarboxylic acid delivery agents
FR2951085B1 (fr) * 2009-10-09 2012-05-18 Inst Substances Vegetales Utilisation de composes phenoliques pour la deglycation des proteines
EA030038B1 (ru) * 2010-10-27 2018-06-29 Прометик Фарма Смт Лимитед Применение соединений для лечения рака и способ лечения рака
WO2014048888A1 (en) * 2012-09-28 2014-04-03 Nestec S.A. Dihydroferulic acid and/or dihydrocaffeic acid for use in the treatment of metabolic diseases
TWI689490B (zh) * 2013-03-15 2020-04-01 英商邊緣生物科技有限公司 用於治療纖維化之經取代之芳族化合物及相關方法
EP3104854B1 (en) 2014-02-10 2020-04-08 Respivant Sciences GmbH Mast cell stabilizers for lung disease treatment
AU2015213678C1 (en) 2014-02-10 2019-03-21 Respivant Sciences Gmbh Mast cell stabilizers treatment for systemic disorders
US10265296B2 (en) 2015-08-07 2019-04-23 Respivant Sciences Gmbh Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
US10238625B2 (en) 2015-08-07 2019-03-26 Respivant Sciences Gmbh Methods for the treatment of mast cell related disorders with mast cell stabilizers
CA3035528A1 (en) 2016-08-31 2018-03-08 Respivant Sciences Gmbh Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
AU2017339366A1 (en) 2016-10-07 2019-04-11 Respivant Sciences Gmbh Cromolyn compositions for treatment of pulmonary fibrosis
EP3573944B1 (en) * 2017-01-30 2022-03-02 ChemCom S.A. Compounds reducing malodour perception and the use thereof
CN109479878B (zh) * 2018-11-28 2021-08-03 华南农业大学 2-甲氧基苯丙酸化合物在预防和/或治疗植物病害中的应用
CN109725090B (zh) * 2019-03-16 2021-05-18 丁立平 一种测定水源水中四种痕量苯丙酸的气相色谱-质谱联用法
CN114414695B (zh) * 2022-01-21 2023-04-21 苏州南医大创新中心 一种与无精子症有关的分子标志物及其检测方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US35862A (en) * 1862-07-08 Improved portable evaporator for saccharine jutces
USRE35862E (en) 1986-08-18 1998-07-28 Emisphere Technologies, Inc. Delivery systems for pharmacological agents encapsulated with proteinoids
US5714167A (en) * 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5443841A (en) * 1992-06-15 1995-08-22 Emisphere Technologies, Inc. Proteinoid microspheres and methods for preparation and use thereof
US5541155A (en) * 1994-04-22 1996-07-30 Emisphere Technologies, Inc. Acids and acid salts and their use in delivery systems
US5401516A (en) * 1992-12-21 1995-03-28 Emisphere Technologies, Inc. Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
DE69434418T2 (de) * 1993-04-22 2005-12-22 Emisphere Technologies, Inc. Orale Dareichungsform
US5643957A (en) * 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US20020119985A1 (en) 1994-11-21 2002-08-29 Albert Gyorkos Serine protease inhibitors
US5866536A (en) * 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
DK0993831T3 (da) * 1997-02-07 2008-03-25 Emisphere Tech Inc Forbindelser og præparater til tilförsel af aktive stoffer
US5776888A (en) * 1997-02-07 1998-07-07 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6656922B2 (en) * 1998-05-28 2003-12-02 Mediplex Corporation, Korea Oral delivery of macromolecules
JP3541007B2 (ja) * 1998-05-28 2004-07-07 メディプレックス コーポレイション、コリア 両親媒性ポリサッカリド誘導体
AU1071200A (en) * 1998-10-19 2000-05-08 Biotech Australia Pty Limited Systems for oral delivery
BR0008590A (pt) 1999-01-08 2001-10-30 Emisphere Tech Inc Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
WO2001032130A2 (en) 1999-11-05 2001-05-10 Emisphere Technologies, Inc. Phenyl amine carboxylic acid compounds and compositions for delivering active agents
BR0114799A (pt) * 2000-09-06 2003-12-30 Emisphere Tech Inc Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
NZ551196A (en) * 2004-05-14 2010-08-27 Emisphere Tech Inc Compounds and compositions for delivering active agents
EP2114145B1 (en) * 2007-02-08 2017-11-01 Emisphere Technologies, Inc. Phenylalkylcarboxylic acid delivery agents
JP5390404B2 (ja) * 2007-02-16 2014-01-15 エミスフェアー・テクノロジーズ・インク 活性薬剤を送達するための環状部分を有する化合物及び組成物

Also Published As

Publication number Publication date
US20160375135A1 (en) 2016-12-29
JP2010518119A (ja) 2010-05-27
BRPI0807285A2 (pt) 2014-05-06
US11253596B2 (en) 2022-02-22
CN105233294A (zh) 2016-01-13
EP2114145A4 (en) 2013-11-06
CA2676930C (en) 2015-09-08
US20110046050A1 (en) 2011-02-24
EP2114145A2 (en) 2009-11-11
CA2676930A1 (en) 2008-09-18
US20120258911A1 (en) 2012-10-11
WO2008112368A2 (en) 2008-09-18
US10456472B2 (en) 2019-10-29
CN101616583A (zh) 2009-12-30
US20200405863A1 (en) 2020-12-31
MX2009008542A (es) 2009-11-10
ES2657484T3 (es) 2018-03-05
WO2008112368A3 (en) 2008-11-20
EP2114145B1 (en) 2017-11-01
JP5544169B2 (ja) 2014-07-09

Similar Documents

Publication Publication Date Title
MX340993B (es) Agentes de suministro de acido fenilalquilcarboxilico.
MX2024013597A (es) Composiciones de nanoparticulas lipidicas para suministro de agentes biologicamente activos
MY153915A (en) Organic compounds
EA201390145A1 (ru) Конъюгаты, частицы, композиции и связанные с ними способы
MY156511A (en) Compositions and devices
EP4403197A3 (en) Injectable formulations for organ augmentation
MX2009006567A (es) Pirimidinilpirazoles como principios activos insecticidas y parasiticidas.
MX2010002285A (es) Combinaciones de principios activos con propiedades insecticidas y acaricidas.
CO6571886A2 (es) Antagonistas de pcsk9
MY142334A (en) Fertilizer-compatible composition
MX2009008347A (es) Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso.
TW200626068A (en) Active compounds for seed treatment
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
UA94749C2 (en) Benzimidazole modulators of vr1
MX2009007266A (es) Formulaciones estables de acido s-(+)-abscisico liquidas y de granulo soluble.
MX2012007375A (es) 3-ceto-n-propargil 1-aminoindano.
MX2009004862A (es) Estabilizacion de vacunas por liofilizacion.
EA201270590A1 (ru) Ингибиторы акт
EA200900267A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ И СТЕРОИДОВ
TW200800967A (en) Benzimidazole thiophene compounds
SG158091A1 (en) Imidazoazepinone compounds
TW200738627A (en) Trialkylsilyl-indoles
TW200738659A (en) Novel compounds
MX2009013708A (es) Uso de derivados de acido tetramico para combatir vectores transmisores de virus.
NZ701463A (en) Anti-phytopathogenic composition

Legal Events

Date Code Title Description
FG Grant or registration